What are the major opportunities in the Pneumonia Therapeutics market? What are the strategies for the Pneumonia Therapeutics market?

For detailed insights on the major opportunities and strategies in the Pneumonia Therapeutics market, Read More

How does the Pneumonia Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Pneumonia Therapeutics market growth and SWOT analysis of the Pneumonia Therapeutics industry, Read More

For detailed insights on the mergers and acquisitions in the Pneumonia Therapeutics industry,

What are the key dynamics influencing the Pneumonia Therapeutics market growth? SWOT analysis of the Pneumonia Therapeutics market. Read More

Global Pneumonia Therapeutics Market Report 2025

Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Pneumonia Therapeutics Global Market Report 2025

Name: Pneumonia Therapeutics Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product (Drugs, Vaccine, Oxygen Therapy ), By Infection (Hospital-Acquired Pneumonia (HAP), Community-Acquired Pneumonia (CAP), Ventilator-Associated Pneumonia (VAP) ), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration ), By End Use (Hospitals, Homecare, Specialty Clinics, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pneumonia Therapeutics Market Overview

• Pneumonia Therapeutics market size has reached to $10.35 billion in 2024

• Expected to grow to $17.11 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%

• Growth Driver: Rising Pneumonia Cases Fuel Demand For Advanced Treatments

• Market Trend: Innovative Approaches To Combating Antibiotic Resistance In Pneumonia Treatment

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pneumonia Therapeutics Market?

Pneumonia therapeutics refer to a range of treatments and medications used to manage and treat pneumonia, a lung infection that are caused by bacteria, viruses, or fungi. These therapeutics target the underlying pathogens, reduce inflammation, and improve respiratory functions. Treatments include antibiotics for bacterial pneumonia, antiviral medications for viral pneumonia, and antifungal agents for fungal infections.

The main products of pneumonia therapeutics are drugs, vaccines, and oxygen therapy. Drugs for pneumonia therapeutics address the root cause (bacteria, viruses, or fungi) and alleviate symptoms through antibiotics, antivirals, antifungals, and supportive treatments such as oxygen therapy. The infections treated comprise hospital-acquired pneumonia (HAP), community-acquired pneumonia (CAP), and ventilator-associated pneumonia (VAP). The routes of administration include oral, parenteral, and other methods and are used by end users such as hospitals, home care, specialty clinics, and others.

Pneumonia Therapeutics Market Size and growth rate 2025 to 2029: Graph

What Is The Pneumonia Therapeutics Market Size 2025 And Growth Rate?

What Is The Pneumonia Therapeutics Market Growth Forecast?

The pneumonia therapeutics market size is expected to see rapid growth in the next few years. It will grow to $17.11 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing antibiotic-resistant strains, growing prevalence of pneumonia in aging populations, expansion of telemedicine for early diagnosis, rising healthcare expenditures in emerging markets, increasing funding for infectious disease research, and heightened awareness campaigns. Major trends in the forecast period include development of monoclonal antibodies, adoption of inhalable antibiotics, innovation in mRNA-based vaccines, AI-driven diagnostic tools, adoption of host-targeted therapies, novel immunomodulators, and advancements in rapid point-of-care diagnostic platforms.

The forecast of 10.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. treatment of severe pneumonia by inflating prices of rapid multiplex Polymerase Chain Reaction panels panels and IV antibiotic formulations developed in India and Spain, resulting in delayed appropriate antibiotic initiation and higher infectious disease management costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Pneumonia Therapeutics Market Segmented?

1) By Product: Drugs, Vaccine, Oxygen Therapy

2) By Infection: Hospital-Acquired Pneumonia (HAP), Community-Acquired Pneumonia (CAP), Ventilator-Associated Pneumonia (VAP)

3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration

4) By End Use: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Drugs: Antibiotics, Antiviral Drugs, Antifungal Drugs, Corticosteroids, Other Drugs

2) By Vaccine: Pneumococcal Vaccines, Haemophilus Influenzae Type B (Hib) Vaccines, influenza vaccines, Other Vaccines

3) By Oxygen Therapy: High-Flow Nasal Cannula (HFNC), Non-Invasive Ventilation (NIV), Mechanical Ventilation, Other Oxygen Therapies

What Is Driving The Pneumonia Therapeutics Market? Rising Pneumonia Cases Fuel Demand For Advanced Treatments

The rising prevalence of pneumonia is expected to drive the growth of the pneumonia therapeutics market going forward. Pneumonia refers to a lung infection that inflames the air sacs, often causing symptoms such as cough, fever, and difficulty breathing. Increasing pneumonia cases can be attributed to factors such as aging populations, air pollution, smoking, weakened immune systems, antimicrobial resistance, and the spread of respiratory infections like COVID-19 or influenza. Pneumonia therapeutics help to combat the infection's cause, such as bacteria, viruses, or fungi, using targeted medications while supporting recovery through oxygen therapy, anti-inflammatory drugs, and symptom management. For instance, in January 2023, according to the National Center for Biotechnology Information, a US-based government agency, globally, pneumonia affects about 120 million people annually, causing approximately 1.3 million deaths. Nearly 80% of pediatric pneumonia deaths occur in children under 2 in developing countries. Therefore, the increasing prevalence of pneumonia is driving the growth of the pneumonia therapeutics industry.

Who Are The Major Players In The Global Pneumonia Therapeutics Market?

Major companies operating in the pneumonia therapeutics market are Pfizer Inc., Roche AG, Merck & Co. Inc., AbbVie Inc, Bayer AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc, Eli Lilly and Company, Astellas Pharma Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Hikma Pharmaceuticals PLC, Shionogi & Co. Ltd, Lupin Limited, Swedish Orphan Biovitrum AB, Nabriva Therapeutics plc, TaiGen Biotechnology Co. Ltd, Aridis Pharmaceuticals Inc., Tergene Biotech Limited.

What Are The Key Trends Of The Global Pneumonia Therapeutics Market? Innovative Approaches To Combating Antibiotic Resistance In Pneumonia Treatment

Major companies operating in the pneumonia therapeutics market focus on developing innovative drug formulations and treatment methods such as antibiotic drugs to address antibiotic resistance and improve patient outcomes. An antibiotic drug refers to a type of medication specifically designed to treat bacterial infections. For instance, in June 2024, Orchid Pharma Limited, an India-based pharmaceutical company, collaborated with Cipla Limited, an India-based pharmaceutical company, to introduce cefepime-enmetazobactam. This antibiotic combination is used to treat complex infections, including UTIs and pneumonia, particularly those resistant to other medications. It helps combat bacterial resistance, ensuring effective treatment while minimizing the need for stronger antibiotics.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Pneumonia Therapeutics Market? GSK Acquires Affinivax To Strengthen Pneumonia Vaccine Portfolio

In August 2022, GSK plc, a UK-based pharmaceutical company, acquired Affinivax Inc. for an undisclosed amount. With this acquisition, Affinivax will continue its operations under GSK’s umbrella, advancing its pioneering work on next-generation pneumococcal vaccines. Affinivax Inc. is a US-based biopharmaceutical company specializes in developing vaccines to prevent pneumonia and other diseases caused by Streptococcus pneumonia.

What Is The Regional Outlook For The Global Pneumonia Therapeutics Market?

North America was the largest region in the pneumonia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pneumonia Therapeutics Market?

The pneumonia therapeutics market consists of revenues earned by entities by providing services such as chest X-rays, blood tests, sputum culture, oxygen supplementation, mechanical ventilation, and telemedicine consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. The pneumonia therapeutics market also includes sales of pneumococcal vaccines, antibiotics, nebulizers, and inhalers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pneumonia Therapeutics Industry?

The pneumonia therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pneumonia therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Pneumonia Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$11.46 billion
Revenue Forecast In 2034	$17.11 billion
Growth Rate	CAGR of 10.6% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The pneumonia therapeutics market covered in this report is segmented – 1) By Product: Drugs, Vaccine, Oxygen Therapy 2) By Infection: Hospital-Acquired Pneumonia (HAP), Community-Acquired Pneumonia (CAP), Ventilator-Associated Pneumonia (VAP) 3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration 4) By End Use: Hospitals, Homecare, Specialty Clinics, Other End Users Subsegments: 1) By Drugs: Antibiotics, Antiviral Drugs, Antifungal Drugs, Corticosteroids, Other Drugs 2) By Vaccine: Pneumococcal Vaccines, Haemophilus Influenzae Type B (Hib) Vaccines, Influenza Vaccines, Other Vaccines 3) By Oxygen Therapy: High-Flow Nasal Cannula (HFNC), Non-Invasive Ventilation (NIV), Mechanical Ventilation, Other Oxygen Therapies
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Roche AG, Merck & Co. Inc., AbbVie Inc, Bayer AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, Novartis AG, GSK plc, Eli Lilly and Company, Astellas Pharma Inc., Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Hikma Pharmaceuticals PLC, Shionogi & Co. Ltd, Lupin Limited, Swedish Orphan Biovitrum AB, Nabriva Therapeutics plc, TaiGen Biotechnology Co. Ltd, Aridis Pharmaceuticals Inc., Tergene Biotech Limited.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Pneumonia Therapeutics Market Characteristics

3. Pneumonia Therapeutics Market Trends And Strategies

4. Pneumonia Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pneumonia Therapeutics Growth Analysis And Strategic Analysis Framework

5.1. Global Pneumonia Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Pneumonia Therapeutics Market Growth Rate Analysis

5.4. Global Pneumonia Therapeutics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Pneumonia Therapeutics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Pneumonia Therapeutics Total Addressable Market (TAM)

6. Pneumonia Therapeutics Market Segmentation

6.1. Global Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Drugs

Vaccine

Oxygen Therapy

6.2. Global Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital-Acquired Pneumonia (HAP)

Community-Acquired Pneumonia (CAP)

Ventilator-Associated Pneumonia (VAP)

6.3. Global Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

Other Route Of Administrations

6.4. Global Pneumonia Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Homecare

Specialty Clinics

Other End Users

6.5. Global Pneumonia Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antibiotics

Antiviral Drugs

Antifungal Drugs

Corticosteroids

Other Drugs

6.6. Global Pneumonia Therapeutics Market, Sub-Segmentation Of Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pneumococcal Vaccines

Haemophilus Influenzae Type B (Hib) Vaccines

Influenza Vaccines

Other Vaccines

6.7. Global Pneumonia Therapeutics Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

High-Flow Nasal Cannula (HFNC)

Non-Invasive Ventilation (NIV)

Mechanical Ventilation

Other Oxygen Therapies

7. Pneumonia Therapeutics Market Regional And Country Analysis

7.1. Global Pneumonia Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Pneumonia Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pneumonia Therapeutics Market

8.1. Asia-Pacific Pneumonia Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pneumonia Therapeutics Market

9.1. China Pneumonia Therapeutics Market Overview

9.2. China Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pneumonia Therapeutics Market

10.1. India Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pneumonia Therapeutics Market

11.1. Japan Pneumonia Therapeutics Market Overview

11.2. Japan Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pneumonia Therapeutics Market

12.1. Australia Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pneumonia Therapeutics Market

13.1. Indonesia Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pneumonia Therapeutics Market

14.1. South Korea Pneumonia Therapeutics Market Overview

14.2. South Korea Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pneumonia Therapeutics Market

15.1. Western Europe Pneumonia Therapeutics Market Overview

15.2. Western Europe Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pneumonia Therapeutics Market

16.1. UK Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pneumonia Therapeutics Market

17.1. Germany Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pneumonia Therapeutics Market

18.1. France Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pneumonia Therapeutics Market

19.1. Italy Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pneumonia Therapeutics Market

20.1. Spain Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pneumonia Therapeutics Market

21.1. Eastern Europe Pneumonia Therapeutics Market Overview

21.2. Eastern Europe Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pneumonia Therapeutics Market

22.1. Russia Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pneumonia Therapeutics Market

23.1. North America Pneumonia Therapeutics Market Overview

23.2. North America Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pneumonia Therapeutics Market

24.1. USA Pneumonia Therapeutics Market Overview

24.2. USA Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pneumonia Therapeutics Market

25.1. Canada Pneumonia Therapeutics Market Overview

25.2. Canada Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pneumonia Therapeutics Market

26.1. South America Pneumonia Therapeutics Market Overview

26.2. South America Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pneumonia Therapeutics Market

27.1. Brazil Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pneumonia Therapeutics Market

28.1. Middle East Pneumonia Therapeutics Market Overview

28.2. Middle East Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pneumonia Therapeutics Market

29.1. Africa Pneumonia Therapeutics Market Overview

29.2. Africa Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pneumonia Therapeutics Market Competitive Landscape And Company Profiles

30.1. Pneumonia Therapeutics Market Competitive Landscape

30.2. Pneumonia Therapeutics Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

31. Pneumonia Therapeutics Market Other Major And Innovative Companies

31.1. Sanofi S.A.

31.2. AstraZeneca PLC

31.3. Abbott Laboratories

31.4. Novartis AG

31.5. GSK plc

31.6. Eli Lilly and Company

31.7. Astellas Pharma Inc.

31.8. Eisai Co. Ltd.

31.9. Sun Pharmaceutical Industries Ltd.

31.10. Cipla Inc.

31.11. Hikma Pharmaceuticals PLC

31.12. Shionogi & Co. Ltd

31.13. Lupin Limited

31.14. Swedish Orphan Biovitrum AB

31.15. Nabriva Therapeutics plc

32. Global Pneumonia Therapeutics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pneumonia Therapeutics Market

34. Recent Developments In The Pneumonia Therapeutics Market

35. Pneumonia Therapeutics Market High Potential Countries, Segments and Strategies

35.1 Pneumonia Therapeutics Market In 2029 - Countries Offering Most New Opportunities

35.2 Pneumonia Therapeutics Market In 2029 - Segments Offering Most New Opportunities

35.3 Pneumonia Therapeutics Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Pneumonia Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Pneumonia Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Pneumonia Therapeutics Market, Sub-Segmentation Of Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Pneumonia Therapeutics Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Pneumonia Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Pneumonia Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Pfizer Inc. Financial Performance

Table 79: Roche AG Financial Performance

Table 80: Merck & Co. Inc. Financial Performance

Table 81: AbbVie Inc Financial Performance

Table 82: Bayer AG Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Pneumonia Therapeutics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Pneumonia Therapeutics Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Pneumonia Therapeutics Market, Sub-Segmentation Of Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Pneumonia Therapeutics Market, Sub-Segmentation Of Oxygen Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Pneumonia Therapeutics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Pneumonia Therapeutics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Pneumonia Therapeutics Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Pneumonia Therapeutics Market, Segmentation By Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Pneumonia Therapeutics Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Pfizer Inc. Financial Performance

Figure 79: Roche AG Financial Performance

Figure 80: Merck & Co. Inc. Financial Performance

Figure 81: AbbVie Inc Financial Performance

Figure 82: Bayer AG Financial Performance

Next-Gen Primary Immunodeficiency Disorders : Market Forecast, Transformation, and Long-Term Trajectories

Proteus Syndrome Growth Trajectory: Key Forecasts and Strategic Insights

Prothrombin Complex Concentrate Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the Prothrombin Complex Concentrate Market Landscape: Advanced Radiation Therapy Systems Enhancing Precision And Patient Outcomes

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Anti-Infective Drugs Global Market Report 2022 – By Type (Antibiotics, Antivirals, Antifungals, Others (Anthelminthic, Antiprotozoal)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others...

Lower Respiratory Tract Therapeutics Global Market Report 2025 – By Disease Type (Asthma, Chronic obstructive pulmonary disease, Pneumonia, Tuberculosis, Bronchitis, Other Diseases), By Drug Class (Antibiotics, Non-Stero...

Anti-Inflammatory Therapeutics Global Market Report 2025 – By Drug Class (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics), By Indication (Arthritis, Respiratory Diseases, Mult...

Infectious Disease Therapeutics Global Market Report 2025 – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharmacies, Res...

Vaginitis Therapeutics Global Market Report 2025 – By Drug Type (Nitroimidazole Compound, Lincosamide Antibiotics, Triazoles, Imidazoles), By Route Of Administration (Oral, Cutaneous, Vaginal), By Indication Type (Bacter...

Pneumococcal Vaccine Global Market Report 2025 – By Product Type (Prevnar 13, Synflorix, Pneumovax23, Other Products), By Route of Administration (Intravenous, Intramuscular, Subcutaneous), By Distribution Channel (Pharm...

Bronchitis Treatment Global Market Report 2025 – By Type (Acute Bronchitis, Chronic Bronchitis), By Treatment (Drugs, Oxygen Therapy), By Distribution Channel (Online Pharmaceutical Stores, Retail Pharmacies, Hospital Ph...

Frequently Asked Questions

What is the definition of the Pneumonia Therapeutics market?

How will the Pneumonia Therapeutics market drivers and restraints affect the market dynamics? What forces will shape the Pneumonia Therapeutics industry going forward?

The market major growth driver - Rising Pneumonia Cases Fuel Demand For Advanced Treatments. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Pneumonia Therapeutics market?

The pneumonia therapeutics market size has grown rapidly in recent years. It will grow from $10.35 billion in 2024 to $11.46 billion in 2025 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to increase in prevalence of drug-resistant strains, rise in awareness of pneumonia prevention, growth in elderly and immunocompromised populations, expanded vaccination programs, and improved healthcare infrastructure. The pneumonia therapeutics market size is expected to see rapid growth in the next few years. It will grow to " $17.11 billion in 2029 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing antibiotic-resistant strains, growing prevalence of pneumonia in aging populations, expansion of telemedicine for early diagnosis, rising healthcare expenditures in emerging markets, increasing funding for infectious disease research, and heightened awareness campaigns. Major trends in the forecast period include development of monoclonal antibodies, adoption of inhalable antibiotics, innovation in mRNA-based vaccines, AI-driven diagnostic tools, adoption of host-targeted therapies, novel immunomodulators, and advancements in rapid point-of-care diagnostic platforms. For further insights on this market, request a sample here

How is the Pneumonia Therapeutics market segmented?

The pneumonia therapeuticsmarket covered in this report is segmented –
1) By Product: Drugs; Vaccine; Oxygen Therapy
2) By Infection: Hospital-Acquired Pneumonia (HAP); Community-Acquired Pneumonia (CAP); Ventilator-Associated Pneumonia (VAP)
3) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
4) By End Use: Hospitals; Homecare; Specialty Clinics; Other End Users Subsegments:
1) By Drugs: Antibiotics; Antiviral Drugs; Antifungal Drugs; Corticosteroids; Other Drugs
2) By Vaccine: Pneumococcal Vaccines; Haemophilus Influenzae Type B (Hib) Vaccines; Influenza Vaccines; Other Vaccines
3) By Oxygen Therapy: High-Flow Nasal Cannula (HFNC); Non-Invasive Ventilation (NIV); Mechanical Ventilation; Other Oxygen Therapies For further insights on this market, request a sample here

Which region has the largest share of the Pneumonia Therapeutics market? What are the other regions covered in the report?

North America was the largest region in the pneumonia therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pneumonia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Pneumonia Therapeutics market?

What are the key trends in the Pneumonia Therapeutics market?

Major trends in this market include Innovative Approaches To Combating Antibiotic Resistance In Pneumonia Treatment. For further insights on this market, request a sample here.